As part of state policy is obviously negotiating with laboratories producing drugs to obtain prices and conditions for not only the continuity of the program but also its expansion. Since November it has been negotiating with Merck and has not reached agreement, the refusal of the laboratory in terms level the price of the drug with the price that gives other countries and given their counter that only lowered the price by 2% Brazil has threatened to “break” the patent and purchase the generic WHO, it has already worked to Brazil in the past with another laboratory, that in such a threat in a little guard, and finally achieving agreed to renegotiate the agreement but for the moment, in this case, Merck has not set position on this statement, I imagine they will be removing accounts. Ultimately and finally, I wanted to highlight is the apparent “awakening” of Lula in the second term and I confess that maybe in the past failed to pay sufficient attention to news about him or his actions but honestly I have the impression than one time now the “mobility”, the energy and determination with which conducts its work have increased, and if your government can mitigate action, if not resolve, the tremendous differences and social conflict which are the main bottlenecks in the final anchor off of their nation, Brazil around a few years can become a center of power at all levels, not insignificant and well above the currently already holds summarized in the cliche of “Giant of the South.”.